跳至主要内容
临床试验/NCT04946565
NCT04946565Unknown不适用

The Impact of Sinopharm COVID-19 Vaccination on Male Fertility of the Egyptian Population

Cairo University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年7月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Total sperm count per ejaculate

研究概览

简要总结

The investigators shall study the effect of Sinopharm vaccination on semen parameters and serum testosterone

详细描述

The investigators shall compare semen parameter (sperm density, sperm motility, and percentage of abnormal sperm form) as well as morning serum testosterone before vaccination, and 3 months after the second dose of the vaccine.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Receiving Sinopharm COVID-19 vaccines Male age 18-50 years old

排除标准

  • Adults unable to consent
  • Men who have been receiving Testosterone replacement therapy or anabolic steroids within the last year
  • Men with a history of male infertility
  • Men with a genetic or other medical condition known to be associated with decreased semen parameters Positive COVID-19 PCR test within the 3 months

结局指标

主要结局

Total sperm count per ejaculate

时间窗: up to 6 months

As measured from semen samples

Percentage of motile sperm

时间窗: up to 6 months

As measured from semen samples

Sperm density count/ml

时间窗: up to 6 months

As measured from semen samples

Percentage of abnormal sperm forms

时间窗: up to 6 months

As measured from semen samples

次要结局

  • Morning serum testosterone(up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Tarek Anis

Professor of Andrology

Cairo University

研究点 (1)

Loading locations...

相似试验